52317

Cystourethroscopy, with Litholapaxy; Complex or Large Calculus (>2.5 cm)

CPT code 52317 describes a complex or large litholapaxy procedure, which involves the crushing or fragmentation of a calculus (stone) within the bladder using various methods, followed by the removal of the fragments. This procedure is performed transurethrally under direct visualization using a cystoscope. The term "complex or large" specifically refers to calculi greater than 2.5 cm in size, which often require more extensive fragmentation, longer operative time, and potentially more advanced techniques compared to smaller stones.Common methods for stone fragmentation include ultrasonic lithotripsy, where high-frequency sound waves break down the stone; electro-hydraulic lithotripsy, which uses a spark-gap electrode to create shock waves; and laser lithotripsy (e.g., Holmium:YAG laser), which ablates the stone into smaller pieces. After fragmentation, the stone fragments are irrigated out of the bladder or removed with grasping forceps or suction devices through the cystoscope. The complexity might also arise from the stone's hardness, shape, multiplicity, or its adherence to the bladder wall. Patients typically receive general or regional anesthesia for this procedure. Post-operatively, a urinary catheter may be placed temporarily to ensure drainage and monitor for bleeding or urinary retention. This minimally invasive technique avoids an open surgical incision, leading to a quicker recovery time for the patient compared to traditional open cystolithotomy.

Clinical Indications

  • Large bladder calculi (greater than 2.5 cm) causing obstructive symptoms such as urinary retention or difficulty voiding.
  • Symptomatic bladder stones causing recurrent urinary tract infections (UTIs).
  • Bladder stones causing hematuria (blood in urine).
  • Bladder stones causing bladder irritation, pain, or discomfort.
  • Stones refractory to conservative management or medical dissolution therapy.
  • Stones in patients who are not candidates for open surgery due to comorbidities.
  • Recurrent bladder stones requiring intervention.

Procedure Steps

  1. Patient positioned in dorsal lithotomy position, and sterile preparation and draping are performed.
  2. Cystoscope (rigid or flexible) is inserted transurethrally into the bladder under direct visualization.
  3. Bladder is distended with sterile irrigant (e.g., saline).
  4. Calculus(i) is identified and assessed for size, number, and location.
  5. Appropriate fragmentation device (e.g., ultrasonic lithotrite, electro-hydraulic probe, laser fiber) is advanced through the working channel of the cystoscope.
  6. Stone is fragmented into smaller pieces using the chosen energy source.
  7. Repeated fragmentation may be necessary for large or hard stones.
  8. Fragments are irrigated out of the bladder using an evacuator (e.g., Ellik or Toomey syringe) or removed with grasping forceps or suction.
  9. Cystoscopy is repeated to ensure complete removal of all significant fragments.
  10. Inspection of the bladder mucosa for any injury or remaining fragments.
  11. A Foley catheter may be inserted temporarily and left in place, especially if significant edema or bleeding is present.
  12. Cystoscope is withdrawn.

Coding Guidelines

  • CPT code 52317 is specifically for complex or large calculi, defined as those greater than 2.5 cm. Do not use this code for stones 2.5 cm or less; use 52318 for simple or small calculi.
  • The procedure includes the crushing or fragmentation by any method (ultrasonic, electro-hydraulic, laser, mechanical) and the removal of fragments.
  • Code 52317 includes cystourethroscopy, which is a component of the procedure and should not be billed separately.
  • If multiple large stones are removed from the bladder during the same operative session, typically only one unit of 52317 is reported as the descriptor implies management of bladder calculi.
  • When a cystoscopic examination is performed prior to the litholapaxy as part of the surgical approach, it is included in the global package of 52317.
  • Modifier -58 (Staged or Related Procedure or Service by the Same Physician or Other Qualified Health Care Professional During the Postoperative Period) may be applicable if a subsequent litholapaxy is performed for residual fragments within the global period, depending on payer policy and documentation.
  • Careful documentation of the stone size, number, and fragmentation method is crucial for proper coding.
  • If ureteral stents are placed or removed during the same session, consult bundling rules; often these are separately billable with appropriate modifiers if distinct procedures.

Associated ICD-10 Codes